TRPC1 and colorectal carcinoma: Furthermore, the Kaplan–Meier survival analysis indicated that CRC patients with higher levels of TRPC1 had a worse outcome (P < 0.001, Fig. 1F), especially in early-stage (I/II) patients, but not in advanced-stage (III/IV) patients (Fig. 1G).